Imperva (IMPV): Takeout In Sight - Oppenheimer

September 23, 2016 6:12 AM EDT

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Oppenheimer analyst, Shaul Eyal, reiterated his Outperform rating on shares of Imperva (NYSE: IMPV) after a Bloomberg article highlighted takeover speculation on the company. The article stated that bids are due in approximately two weeks and potential buyers include CSCO, IBM, FTNT, AKAM, and privately held Forcepoint.

The analyst sees the potential price target ranging between $55 and $60, which would indicate a range of 4.6x-5x EV/FY18E revenue. No change to the price target of $60.

For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.

Shares of Imperva closed at $43.39 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment